Develops drugs for genetically defined cancers.
Jun 2026Revenue $0.00/yrExpenses $51.9M/yr
No trendCash runway ≈ 3.4 years from Jun 2026
Figures by year
When will Black Diamond Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $0.00 and expenses $51.9M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $70.0M | $57.5M | $12.5M |
| Dec 2024 | $0.00 | $78.8M | −$78.8M |
| Dec 2020 | $0.00 | $69.6M | −$69.6M |
| Dec 2019 | $0.00 | $29.3M | −$29.3M |
| Dec 2018 | $0.00 | $8.90M | −$8.90M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.